Thank you!

Your quote has been successfully submitted!

For products requiring additional information, our team will contact you within 1 business day

Failed

There was an error submitting your quote. Please try again.

MSE PRO 2-Methyl-2,6-diazaspiro[3.4]octane, ≥97.0% Purity– MSE Supplies LLC

Free Shipping on MSE PRO Online Orders of $500 or More! U.S. Orders Only * Offer Excludes Hazmat Shipments *

Menu
Cart

This product has been added to the cart.

MSE PRO 2-Methyl-2,6-diazaspiro[3.4]octane, ≥97.0% Purity - MSE Supplies LLC

MSE PRO 2-Methyl-2,6-diazaspiro[3.4]octane, ≥97.0% Purity

SKU: CM1359

  • $ 89995

MSE PRO™ 2-Methyl-2,6-diazaspiro[3.4]octane, ≥97.0% Purity

MSE PRO™ 2-Methyl-2,6-diazaspiro[3.4]octane is a highly valuable compound in the pharmaceutical industry, commonly used as a building block in organic synthesis. Its spirocyclic structure allows for the development of innovative compounds with potential pharmacological benefits. Experts in the field are presently exploring its potential as a precursor or intermediate in developing innovative drug candidates, particularly targeting central nervous system disorders and infectious diseases.

MSE Supplies offers various N-heterocyclic drug small molecules. Please contact us for bulk orders.

Technical Specifications:

CAS No. 135380-30-2
Chemical name 2-Methyl-2,6-diazaspiro[3.4]octane
Synonym(s)

  • 2-Methyl-2,6-diazaspiro[3.4]octane oxalate

  • 2-Methyl-2,6-diazaspiro[3.4]octane
Molecular formula C7H14N2
Pack size

1 g (CM1359)
Molecular weight 126.20 g/mol
Boiling point  177.5±8.0 °C (Predicted)
Density  1.03±0.1 g/mL (Predicted)  
Purity ≥97.0% (NMR)
pKa
 		10.96±0.20 (Predicted)
Appearance Colorless to light yellow liquid
Storage  2-8°C, protect from light


References:

[1] Weinberg, K., Stoit, A., Kruse, C. G., Haddow, M. F., & Gallagher, T. (2013). Synthesis and differential functionalisation of pyrrolidine and piperidine based spirodiamine scaffolds. Tetrahedron, 69(23), 4694-4707.

[2] Ji, Y., Wang, L., Zhou, R., Yang, X., Li, S., Cen, S., & Li, Y. (2024). Design, synthesis, and antiviral activity of 1-aryl-4-arylmethylpiperazine derivatives as Zika virus inhibitors with broad antiviral spectrum. Bioorganic & Medicinal Chemistry, 103, 117682.